132 related articles for article (PubMed ID: 9704758)
21. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A).
Giannini S; Maggi M; Cresci B; Finetti G; Bonaccorsi L; Luconi M; Rotella CM; Forti G; Serio M; Baldi E
Gynecol Oncol; 1996 Jun; 61(3):333-40. PubMed ID: 8641611
[TBL] [Abstract][Full Text] [Related]
24. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E
Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238
[TBL] [Abstract][Full Text] [Related]
25. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
26. Regulation of PTP1D mRNA by peptide growth factors in the human endometrial cell line HEC-1-A.
Burke JJ; Talavera F; Menon KM
J Soc Gynecol Investig; 1997; 4(6):310-5. PubMed ID: 9408887
[TBL] [Abstract][Full Text] [Related]
27. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.
Cong L; Gasser J; Zhao J; Yang B; Li F; Zhao AZ
Endocr Relat Cancer; 2007 Sep; 14(3):713-20. PubMed ID: 17914101
[TBL] [Abstract][Full Text] [Related]
28. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
[TBL] [Abstract][Full Text] [Related]
29. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
30. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.
Fleck JF; Sledge GW; Benenati SV; Frolik CA; Roth BJ; Hirsch KS
Cancer Res; 1991 Aug; 51(16):4395-401. PubMed ID: 1678315
[TBL] [Abstract][Full Text] [Related]
31. [Cell cycle analysis of endometrial cancer cells in vitro treated with growth factor and steroid hormone].
Oyama S; Izutsu T
Hum Cell; 1992 Dec; 5(4):363-71. PubMed ID: 1304800
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone.
Engel JB; Keller G; Schally AV; Toller GL; Groot K; Havt A; Armatis P; Zarandi M; Varga JL; Halmos G
J Clin Endocrinol Metab; 2005 Jun; 90(6):3614-21. PubMed ID: 15784701
[TBL] [Abstract][Full Text] [Related]
33. Mitogenic effects of human recombinant insulin on B-cell precursor acute lymphoblastic leukemia cells.
Neely EK; Rosenfeld RG; Illescas A; Smith SD
Leukemia; 1992 Nov; 6(11):1134-42. PubMed ID: 1434795
[TBL] [Abstract][Full Text] [Related]
34. The Anticancer Effects of Radachlorin-mediated Photodynamic Therapy in the Human Endometrial Adenocarcinoma Cell Line HEC-1-A.
Kim SM; Rhee YH; Kim JS
Anticancer Res; 2017 Nov; 37(11):6251-6258. PubMed ID: 29061808
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
36. Growth-promoting effect, biological activity, and binding of insulin in human intestinal cancer cells in culture.
Cezard JP; Forgue-Lafitte ME; Chamblier MC; Rosselin GE
Cancer Res; 1981 Mar; 41(3):1148-53. PubMed ID: 7006801
[TBL] [Abstract][Full Text] [Related]
37. Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
Westphalen S; Kotulla G; Kaiser F; Krauss W; Werning G; Elsasser HP; Nagy A; Schulz KD; Grundker C; Schally AV; Emons G
Int J Oncol; 2000 Nov; 17(5):1063-9. PubMed ID: 11029513
[TBL] [Abstract][Full Text] [Related]
38. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma.
Bui TD; Zhang L; Rees MC; Bicknell R; Harris AL
Br J Cancer; 1997; 75(8):1131-6. PubMed ID: 9099960
[TBL] [Abstract][Full Text] [Related]
39. Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells.
Bermont L; Lamielle F; Lorchel F; Fauconnet S; Esumi H; Weisz A; Adessi GL
J Clin Endocrinol Metab; 2001 Jan; 86(1):363-8. PubMed ID: 11232025
[TBL] [Abstract][Full Text] [Related]
40. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B.
Cuevas ME; Lindeman TE
Oncol Rep; 2015 Jan; 33(1):464-70. PubMed ID: 25351552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
